Related Experiment Video
Updated: May 21, 2026

10:02
piggyBac Transposon System Modification of Primary Human T Cells
Published on: November 5, 2012
Il2rg gene-targeted severe combined immunodeficiency pigs
Shunichi Suzuki1, Masaki Iwamoto2, Yoriko Saito3
1Transgenic Animal Research Center, National Institute of Agrobiological Sciences, Tsukuba, Ibaraki 305-0901, Japan.
Cell Stem Cell
|June 19, 2012
Summary
Researchers developed a novel porcine model of severe combined immunodeficiency (SCID) by disrupting the Il2rg gene. This SCID pig model is crucial for advancing cancer research and regenerative medicine therapies.
Area of Science:
- Immunology
- Genetics
- Animal Models
Background:
- Severe combined immunodeficiency (SCID) models are essential for studying immune deficiencies and developing therapies.
- A well-characterized porcine SCID model has been lacking, hindering advancements in human disease research and regenerative medicine.
Purpose of the Study:
- To generate and evaluate a porcine model of severe combined immunodeficiency (SCID).
- To establish a preclinical tool for human cancer studies, xenotransplantation, and stem cell therapy evaluation.
Main Methods:
- Generation of cloned pigs using fibroblasts with a targeted disruption of the interleukin-2 receptor gamma chain (Il2rg) gene.
- Serial nuclear transfer technique was employed for cloning.
- Evaluation of lymphoid lineage reconstitution following allogeneic bone marrow transplantation.
Main Results:
- Successful generation of pigs with germline transmission of the Il2rg deletion.
- Il2rg(-/Y) male pigs exhibited athymia and impaired immunoglobulin, T cell, and NK cell production, mirroring human SCID.
- Donor cells stably integrated and reconstituted the lymphoid lineage in Il2rg(-/Y) heterozygotes post-transplantation.
Conclusions:
- The developed porcine SCID model accurately recapitulates human SCID.
- This model provides a valuable platform for preclinical evaluation of cellular regenerative strategies and cancer research.
- The study represents a significant step towards advancing clinical therapies using animal models.
